SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-088829
Filing Date
2021-07-02
Accepted
2021-07-02 16:01:27
Documents
2
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120855d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2120855d1_3.xml 3 1635
2 EXHIBIT 24 tm2120855d1_ex24.htm EX-24 3594
  Complete submission text file 0001104659-21-088829.txt   6768
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELLECTAR BISCIENCES, INC. 100 CAMPUS DRIVE NJ 07932
Business Address
Chanan-Khan Asher (Reporting) CIK: 0001869837 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 211069827